AI-Assisted Pathology Slide Analysis System PathAI: Cancer Diagnosis Cut From 3 Days to 45 Minutes

PathAI, the latest version of the pathology analysis system from US medical AI company PathAI, has cut cancer diagnosis time from the traditional three days to 45 minutes. The efficiency gain comes mainly from AI pre-analysis of pathology slides, which lets pathologists focus on the critical judgment steps.

The conventional cancer pathology workflow requires the removed tumor tissue to be sliced, stained, scanned, and examined by a pathologist under a microscope. The entire process takes more than 72 hours, which can cause patients with fast-progressing cancers to miss the optimal treatment window.

PathAI first digitizes the slide through a full scan, then uses a deep learning model to automatically identify regions with abnormal cells. Pathologists can use the system's highlighted annotations to locate critical areas quickly, which lifts efficiency significantly. In a multi-center trial at Johns Hopkins Hospital, agreement between the system's diagnosis and the pathologists' independent diagnosis reached 96.2 percent.

PathAI CEO Andy Beck said the company's goal is to turn cancer diagnosis from "waiting for results" into "instant feedback," letting patients walk out of the visit with a clear diagnosis the same day.